Lecanemab for Alzheimer's disease: new hope or another false dawn?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lecanemab for Alzheimer's disease: new hope or another false dawn?

Published:2023-01 Issue:1 Volume:27 Page:4-6
ISSN:1367-7543
Container-title:Progress in Neurology and Psychiatry
language:en
Short-container-title:Prog Neurol Psychiatry

Author:

Dashwood Mark¹,Kuruvilla Tarun¹

Affiliation:

1. Dr Dashwood is a Psychiatry Registrar and Professor Kuruvilla is a Consultant Psychiatrist, Clinical Director for Research & Visiting Professor at the School of Health & Social Care, University of Gloucestershire. Both are based at Gloucestershire Health & Care NHS Foundation Trust.

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,Pshychiatric Mental Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pnp.772

Reference18 articles.

1. Amyloid Precursor Protein (APP) and ΒZA4 Amyloid in the Etiology of Alzheimer's Disease: Precursor-Product Relationships in the Derangement of Neuronal Function

2. Amyloid deposition as the central event in the aetiology of Alzheimer's disease

3. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

4. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics

5. Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP